Melissa Tosca
Director Financiero/CFO en KIORA PHARMACEUTICALS, INC. .
Fortuna: 16 752 $ al 30/04/2024
Perfil
Melissa Tosca is currently working as the EVP-Finance, Chief Financial & Accounting Officer at Kiora Pharmaceuticals, Inc. She also holds the position of Executive Vice President-Finance at the same company.
Previously, she worked at Neomorph, Inc. as the Treasurer & Executive Director-Finance.
Ms. Tosca completed her undergraduate degree at the University of Arizona.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/03/2024 | 34 900 ( 0.13% ) | 16 752 $ | 30/04/2024 |
Cargos activos de Melissa Tosca
| Empresas | Cargo | Inicio |
|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director Financiero/CFO | - |
Antiguos cargos conocidos de Melissa Tosca.
| Empresas | Cargo | Fin |
|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Director Financiero/CFO | - |
Formación de Melissa Tosca.
| University of Arizona | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Melissa Tosca
